EUROAPI Hungary Ltd.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Lessors of Real Property, Not Elsewhere Classified, Land Subdividers and Developers, Except Cemeteries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Divestitures and Spin-offs (13)
Inter-Organizational Collaborations (10)
Financial Reporting (6)
Acquisition Announcements (5)
New Product Release (5)
Business Growth Initiatives (5)
Corporate Announcements (4)
Investment Strategies (4)
Competitive Market Dynamics (4)
Manufacturing Disruptions (4)
Stock Market Events (4)
Executive Leadership Changes (3)
Market Trends (3)
Corporate Restructuring (2)
Corporate Misconduct (2)
Funding Announcements (2)
Government Policy Developments (2)
Corporate Financing Plans (2)
Corporate Deals (2)
Capital Funding Requests (2)
Sustainable Practices (2)
Tech Innovation & Advancements (2)
Sustainable Finance (1)
Customs and Tariff Regulations (1)
Workplace Ethics & Policies (1)
Employee Engagement and Inclusion Initiatives (1)
Environmental Assessments (1)
Asset Valuation (1)
Corporate Insolvency (1)
Public Health Crisis Response (1)
Recent Articles about EUROAPI Hungary Ltd.
Live alerts from global media, monitored by Business Radar
2023-10-09 (fiercepharma.com)
In cutting sales guidance, EuroAPI cites CDMO industry struggles and customers' inventory reductions
Flush with business during the COVID pandemic, the CDMO industry is struggling to adjust in the aftermath. | Flush with business during the COVID pandemic, the CDMO industry is struggling to adjust in the aftermath.
Read more